From chloroquine to artemisinin-based combination therapy: The Sudanese experience

Malaria Journal

Volumn 5, Issue , 2006, Pages

  Malik, E M ^a   Mohamed, T A ^a   Elmardi, K A ^a   Mowien, R M ^a   Elhassan, A H ^a   Elamin, S B ^a   Mannan, A A ^a   Ahmed, E S ^b  

^a National Malaria Control Programme   (Sudan)

^b UNIVERSITY OF JUBA   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; CHLOROQUINE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ DERIVATIVE; ARTESUNATE; BENFLUMETOL; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FANASIL, PYRIMETHAMINE DRUG COMBINATION; FLUORENE DERIVATIVE; PYRIMETHAMINE; SESQUITERPENE; SULFADOXINE;

ARTICLE; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; MALARIA FALCIPARUM; MEDICAL EDUCATION; MEDICAL PRACTICE; PERSONAL EXPERIENCE; PRACTICE GUIDELINE; SUDAN; DRUG COMBINATION; MALARIA, FALCIPARUM; POSTMARKETING SURVEILLANCE; TIME;

ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FLUORENES; HEALTH POLICY; HUMANS; MALARIA, FALCIPARUM; PRODUCT SURVEILLANCE, POSTMARKETING; PYRIMETHAMINE; SESQUITERPENES; SUDAN; SULFADOXINE; TIME FACTORS;

EID: 33749511232     PISSN: 14752875     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-5-65     Document Type: Article

References (47)

1. Malik EM, Saeed OK: Malaria in Sudan: past, present and the future. Gazera Journal of Health Sciences 2004, 1:47-53.
2. Himeidan Yel-S, Dukeen MY, El-Rayah el-A, Adam I: Anopheles arabiensis: abundance and insecticide resistance in an irrigated area of eastern Sudan. East Mediterr Health J 2004, 10:167-174.
3. Abdel-Hameed AA: Antimalarial drug resistance in the Eastern Mediterranean Region. East Mediterr Health J 2003, 9:492-508.
4. Malik EM, Nour SM, Hamid IK, Elmardi KA, Mohamed TA, Ahmed ES: From home to hospital: Beliefs and practices related to severe malaria in Sudan. Journal of Family & Community Medicine 2005, 12:85-90.
5. Yousif MA, Adeel AA: Antimalarials prescribing pattern in Gazera State: precepts and practices. East Mediterr Healh J 2000, 6:939-947.
6. WHO: Malaria control today: Current WHO Recommendations. RBM Department; WHO, Geneva; 2005.
7. Omer AH: Response of Plasmodium falciparum in Sudan to oral chloroquine. Am J Trop Med Hyg 1978, 27:853-857.
8. Bayoumi RA, Babiker HA, Ibrahim SM, Ghalib HW, Saeed BO, Khider S, Elwasila M, Karim EA: Chloroquine-resistant Plasmodium falciparum in eastern Sudan. Acta Trop 1989, 46:157-165.
9. Saeed BO, Hassabalrasoul MA, Ibrahim KE, Abdel-Karim EI, Salih SA, Hassan IM, Khider S, Bayoumi RA: Plasma chloroquine measurement in the evaluation of Plasmodium falciparum sensitivity. J Trop Med Hyg 1990, 93:393-6.
10. Ibrahim AM, Ali FR, Ali ME: Assessment of chloroquine resistance of Plasmodium falciparum in children of Wad Medani (Central Sudan). J Trop Pediatr 1992, 38:162-6.
11. Elkheir HK, Elkarim EF, Eltayeb IB, Elkadaru AE, Babiker HA, Ibrahim AM: Efficacy of Sulphadoxine and Pyrimethamine, Doxycycline and their combination in the treatment of chloroquine resistant Falciparum Malaria. Saudi Med J 2001, 22:690-3.
12. Abdel-Hameed AA, El-Jak IE, Faragalla IA: Sentinel posts for monitoring therapeutice efficacy of antimalarial drugs against Plasmodium falciparum infections in the Sudan. Afr J Med Sci 2001, 30:1-5.
13. Adam I, Osman ME, Elghzali G, Ahmed GI, Gustafssons LL, Elbashir MI: Efficacies of chloroquine, sulfadoxine-pyrimethamine and quinine in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. Ann Trop Med Parasitol 2004, 98:661-6.
14. van den Broek IV, Gatkoi T, Lowoko B, Nzila A, Ochong E, Keus K: Chloroquine, sulfadoxine-pyrimethamine and amodiaquine efficacy for the treatment of uncomplicated Plasmodium falciparum malaria in Upper Nile, south Sudan. Trans R Soc Trop Med Hyg 2003, 97:229-35.
15. Stivanello E, Cavailler P, Cassano F, Omar SA, Kariuki D, Mwangi J, Piola P, Guthmann JP: Efficacy of chloroquine, sulphadoxinepyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan. Trop Med Int Health 2004, 9:975-80.
16. Adam I, Ibrahim MH, A-elbasit IA, Elbashir MI: Efficacy of sulfadoxine/ pyrimethamine for uncomplicated Plasmodium falciparum malaria in a small sample of Sudanese children. East Mediterr Health J 2004, 10:309-14.
17. Salah MT, Mohammed MM, Himeidan YE, Malik EM, Elbashir MI, Adam I: A randomized comparison of sulphadoxine-pyrimethamine and combination of sulphadoxine pyrimethamine with chloroquine in the treatment of uncomplicated falciparum malaria in Eastern Sudan. Saudi Med J 2005, 26:147-8.
18. Adam I, A-Elbasit IE, Idris SM, Malik EM, Elbashir MI: A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. Ann Trop Med Parasitol 2005, 99:449-55.
19. Abdu Z, Mohammed Z, Bashier I, Eriksson B: The impact of user fee exemption on service utilization and treatment seeking behaviour: the case of malaria in Sudan. Int J Health Plann Manage 2004, 19:S95-106.
20. Adam I, A-Elbasit IE, Elbashir MI: Efficacies of mefloquine alone and of artesunate followed by mefloquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. Ann Trop Med Parasitol 2005, 99:111-7.
21. Hamour S, Melaku Y, Keus K, Wambugu J, Atkin S, Montgomery J, Ford N, Hook C, Checchi F: Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations. Trans R Soc Trop Med Hyg 2005, 99:548-54.
22. van den Broek I, Amsalu R, Balasegaram M, Hepple P, Alemu E, Hussein el B, Al-Faith M, Montgomery J, Checchi F: Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan. Malar J 2005, 4:14.
23. Elamin SB, Malik EM, Abdelgadir T, Khamiss AH, Mohammed MM, Ahmed ES, Adam I: Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan. Malar J 2005, 14;4:41.
24. Mohamed AO, Eltaib EH, Ahmed OA, Elamin SB, Malik EM: The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan. Ann Trop Med Parasitol 2006, 100:5-10.
25. Barat LM, Himonga B, Nkunika S, Ettling M, Ruebush TK, Kapelwa W, Bloland PB: A systematic approach to the development of a rational malaria treatment policy in Zambia. Trop Med Int Health 1998, 3:535-42.
26. Checchi F, Roddy P, Kamara S, Williams A, Morineau G, Wurie AR, Hora B, Lamotte N, Baerwaldt T, Heinzelmann A, Danks A, Pinoges L, Oloo A, Durand R, Ranford-Cartwright L, Smet M, Sierra Leone Antimalarial Efficacy Study Collaboration: Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. Trop Med Int Health 2005, 10:146-53.
27. East African Network for Monitoring Antimalarial Treatment (EANMAT): The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop Med Int Health 2003, 8:860-7.
28. Kamya MR, Bakyaita NN, Talisuna AO, Were WM, Staedke SG: Increasing antimalarial drug resistance in Uganda and revision of the national drug policy. Trop Med Int Health 2002, 7:1031-41.
29. Shretta R, Omumbo J, Rapuoda B, Snow RW: Using evidence to change antimalarial drug policy in Kenya. Trop Med Int Health 2000, 5:755-64.
30. [http://cohred.org/cohred/Home.action].
31. Babiker HA, Satti G, Ferguson H, Bayoumi R, Walliker D: Drug resistant Plasmodium falciparum in an area of seasonal transmission. Acta Trop 2005, 94:260-8.
32. Ndyomugyenyi R, Magnussen P, Clarke S: The efficacy of chloroquine, sulfadoxine-pyrimethamine and a combination of both for the treatment of uncomplicated Plasmodium falciparum malaria in an area of low transmission in western Uganda. Trop Med Int Health 2004, 9:47-52.
33. Plowe CV, Kublin JG, Dzinjalamala FK, Kamwendo DS, Mukadam RA, Chimpeni P, Molyneux ME, Taylor TE: Sustained clinical efficacy of sulfadoxine- pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study. BMJ 2004, 328:545.
34. Bloland PB, Ettling M, Meek S: Combination therapy for malaria in Africa: hype or hope? Bull World Health Organ 2000, 78:1378-88.
35. Bloland PB, Ettling M: Making malaria-treatment policy in the face of drug resistance. Ann Trop Med Parasitol 1999, 93:5-23.
36. Mutabingwa TK: Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Acta Trop 2005, 95:305-15.
37. Agnamey P, Brasseur P, Cisse M, Gaye O, Dumoulin J, Rigal J, Taylor WR, Olliaro P: Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal. Trop Med Int Health 2005, 10:926-33.
38. Bjorkman A, Bhattarai A: Public health impact of drug resistant Plasmodium falciparum malaria. Acta Trop 2005, 94:163-9.
39. Trape JF: The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 2001, 64:12-7.
40. Zucker JR, Ruebush TK, Obonyo C, Otieno J, Campbell CC: The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya. Am J Trop Med Hyg 2003, 68:386-90.
41. Muheki C, McIntyre D, Barnes KI: Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Trop Med Int Health 2004, 9:959-66.
42. Nuwaha F: The challenge of chloroquine-resistant malaria in sub-Saharan Africa. Health Policy Plan 2001, 16:1-12.
43. Williams HA, Durrheim D, Shrett R: The process of changing national malaria treatment policy: lessons from countrylevel studies. Health Policy Plan 2004, 19:356-70.
44. Zurovac D, Ndhlovu M, Rowe AK, Hamer DH, Thea DM, Snow RW: Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study. BMJ 2005, 331:734-9.
45. Abdu Z, Mohammed Z, Bashier I, Eriksson B: The impact of user fee exemption on service utilization and treatment seeking behaviour: the case of malaria in Sudan. Int J Health Plann Manage 2004, 19:S95-106.
46. WHO: Access to Antimalarial Medicines: Improving the affordability and financing of artemisinin-based combination therapies. WHO/CDS/MAL/2003.1095, Geneva.
47. Snow RW, Eckert E, Teklehaimanot A: Estimating the needs for artesunate-based combination therapy for malaria casemanagement in Africa. Trends Parasitol 2003, 19:363-9.